Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

897
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
897
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

6.6K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
6.6K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

1.7K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.7K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

1.4K
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.4K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

3.3K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
3.3K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

1.8K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the Deligation of Large Arteries by the Application of Two Ligatures and the Division of the Vessel between Them.

British medical journal·2010
Same author

Suppurative Otitis Media: Perforation of Mastoid: Trephining and Exploration of the Temporo-Sphenoidal Lobe.

British medical journal·2010
Same author

H1N1 infection mimicking the clinical presentation of gastrointestinal GVHD in a patient following allo-SCT.

Bone marrow transplantation·2010
Same author

Ultrasound imaging of the patellar tendon attachment to the tibia during puberty: a 12-month follow-up in tennis players.

Scandinavian journal of medicine & science in sports·2009
Same author

FRET analysis of actin-myosin interaction in contracting rat aortic smooth muscle.

Canadian journal of physiology and pharmacology·2009
Same author

Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.

Hematological oncology·2008

Related Experiment Video

Updated: Apr 5, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.2K

Ten years' experience with continuous ambulatory peritoneal dialysis.

C Rotellar1, J Black, J F Winchester

  • 1Department of Medicine, Georgetown University Medical Center, Washington, DC 20007.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|February 1, 1991
PubMed
Summary

Continuous ambulatory peritoneal dialysis (CAPD) offers a viable long-term treatment for chronic renal failure. This study shows patient survival rates and discusses major complications, suggesting CAPD as a valuable dialysis option.

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.4K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

3.0K

Related Experiment Videos

Last Updated: Apr 5, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.2K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.4K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

3.0K

Area of Science:

  • Nephrology
  • Internal Medicine

Background:

  • Continuous ambulatory peritoneal dialysis (CAPD) and continuous cyclic peritoneal dialysis (CCPD) are established renal replacement therapies.
  • Long-term outcomes and complication profiles for these techniques require ongoing evaluation.

Purpose of the Study:

  • To evaluate the long-term patient survival, technique survival, and complication rates associated with CAPD and CCPD.
  • To assess the viability of CAPD as an alternative to intermittent hemodialysis for chronic renal failure management.

Main Methods:

  • Retrospective analysis of 171 CAPD and 17 CCPD patients trained up to January 1989.
  • Data collection included patient survival, technique survival, and incidence of major complications over a 10-year period.
  • Survival rates were analyzed for the overall patient population and specifically for diabetic patients.

Main Results:

  • Over 10 years, 5,068 patient-months of experience were accumulated.
  • Overall patient survival was 60% at 5 years and 31% at 10 years.
  • Diabetic patients had a 5-year survival of 32%. Major complications included peritonitis (499 episodes) and exit-site infections (304 episodes). Technique survival was 62% at 5 years and 40% at 10 years.

Conclusions:

  • CAPD demonstrates viability as a long-term dialysis treatment for chronic renal failure.
  • The study supports offering CAPD as a comparable option to intermittent hemodialysis.
  • Careful monitoring for complications such as peritonitis and exit-site infections is crucial for successful long-term CAPD therapy.